Kura Oncology (KURA) Other financing activities (2021 - 2026)
Kura Oncology (KURA) reported Other financing activities of $69000.0 for Q1 2026, down 51.75% year-over-year from $143000.0 in Q1 2025, and down 86.6% quarter-over-quarter from $515000.0 in Q2 2025.
Kura Oncology (KURA) Other financing activities (2021 - 2026) Analysis & Trends
Kura Oncology (KURA) has 6 years of Other financing activities data on file, last reported at $69000.0 in Q1 2026.
- Other financing activities for Q1 2026 came in at $69000.0, down 51.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (down 75.23% YoY), and the FY2025 annual result was $1.8 million, down 79.16% from the prior year.
- Other financing activities declined to $69000.0 in Q1 2026 per KURA's latest filing, from $515000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $3.0 million in Q2 2024 and troughed at $69000.0 in Q1 2026.
- A 5-year average of $1.1 million and a median of $567000.0 in 2022 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2024 and 2025: Other financing activities jumped 2521.43% in 2024, then tumbled 94.4% in 2025.
- A 5-year view of Other financing activities shows it stood at $567000.0 in 2022, then tumbled by 85.19% to $84000.0 in 2023, then soared by 860.71% to $807000.0 in 2024, then plunged by 36.18% to $515000.0 in 2025, then slumped by 86.6% to $69000.0 in 2026.
- Business Quant data shows KURA's Other financing activities at $69000.0 in Q1 2026, $515000.0 in Q2 2025, and $143000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,000.00 |
| Mar 31, 2026 | 69,000.00 |
| Jun 30, 2025 | 515,000.00 |
| Jun 30, 2025 | 515,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Dec 31, 2024 | 807,000.00 |
| Dec 31, 2024 | 807,000.00 |
| Sep 30, 2024 | 2.20 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Sep 30, 2023 | 84,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Jun 30, 2023 | 431,000.00 |
| Jun 30, 2023 | 431,000.00 |
| Dec 31, 2022 | 567,000.00 |
| Dec 31, 2022 | 567,000.00 |